Patents
Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
08/2007
08/09/2007US20070185159 Novel Nitrogen-Containing Heteroaryl Compounds And Methods of Use Thereof
08/08/2007EP1814858A2 Novel crystalline forms of nelfinavir mesylate
08/08/2007EP1814838A2 Prodrugs of (2r)-2-propyloctanoic acid for treatment of stroke
08/08/2007EP1814550A2 N-sulfonylpiperidine cannabinoid receptor 1 antagonists
08/08/2007EP1708994B1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
08/08/2007CN1330657C Novel piperidine and piperazine derivatives
08/08/2007CN101014573A 5-HT7 receptor antagonists
08/08/2007CN101014565A Diarylsulfones as 5-HT2a antagonists
08/07/2007US7253172 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
08/02/2007US20070179142 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
08/01/2007EP1812399A2 Opiate intermediates and methods of synthesis
08/01/2007CN101010301A 5-HT7 receptor antagonosts
08/01/2007CN101007803A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
08/01/2007CN101007784A Antibacterial agents
07/2007
07/31/2007US7250526 Transfer hydrogenation process and catalyst
07/31/2007US7250512 An iridium complex of 2-(2-thienyl)-5-trifluoromethyl)pyridine compounds; light-emitting diodes
07/26/2007WO2007054966A3 A process for the preparation of highly pure crystalline quinapril hydrochloride
07/26/2007US20070173530 6-Aminoisoquinoline Compounds
07/26/2007US20070173529 isoquinoline ring joined to a phenyl ring by a chemical group that is two bonds long and at least one cation or cationic group selected from sodium, potassium, ammonium, and tetraalkylammonium; Factor Xa inhibitor; anticoagulant; straightforward and economical synthesis
07/26/2007US20070173528 Process for preparing solifenacin
07/25/2007EP1809284A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment
07/25/2007EP1177187B1 Di-aryl acid derivatives as ppar receptor ligands
07/25/2007CN1328263C Tetrahydroisoquinoline derivative, its preparation method and pharmaceutical composition
07/25/2007CN101006059A Substituted tetrahydroisoquinolines used in the form of MMP inhibitors, method for the production and use thereof in the form of drugs
07/25/2007CN101005835A 1-[(3r)-amino-4-(2-fluoro-phenyl)-butyl]-pyrrolidine-(2r)-carboxylic acid-benzyl amine derivatives and related compounds as dipeptidyl-peptidase iv (dpp-iv) inhibitors for the treatment of type 2 diab
07/24/2007US7247756 1,4-disubstituted benzenes as insecticides
07/24/2007US7247644 Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgestics
07/19/2007WO2007082131A1 Process for the preparation of hydroxy substituted heterocycles
07/19/2007WO2007080140A1 Cyclohexyl piperazinyl methanone derivatives and their use as histamine h3 receptor modulators
07/19/2007WO2007079957A1 Substituted propiolic acid amides and their use for producing drugs
07/19/2007US20070167626 Electron transport compound and organic light emitting device comprising the same
07/19/2007US20070167444 Benzamide derivative or salt thereof
07/19/2007US20070167425 Compound capable of binding s1p receptor and pharmaceutical use thereof
07/19/2007CA2635719A1 Cyclohexyl piperazinyl methanone derivatives and their use as histamine h3 receptor modulators
07/19/2007CA2633722A1 Substituted propiolic acid amides and their use for producing drugs
07/18/2007EP1807393A1 Diarylsulfones as 5-ht2a antagonists
07/17/2007US7244845 Silylating a heterocyclic carboxylic acid, then chlorination, then sulfonation, to produce (R)-2-(4'-isopropoxycarbonylaminobiphenyl-4-sulfonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid; matrix metalloproteinase inhibitors
07/17/2007US7244766 Sulfonamide derivatives for the treatment of diseases
07/12/2007WO2006058201A3 Heterocyclic and bicyclic compounds, compositions and methods
07/12/2007US20070161670 Process for the preparation of substituted heterocycles
07/11/2007EP1805155A1 Thrombopoietin activity modulating compounds and methods
07/11/2007EP1355886B1 Fused heterocyclic compounds
07/11/2007CN1325476C Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, noval compounds thereof and their use as chemotherapeutic agents
07/10/2007US7241811 Amide compounds for the potentiation of cholinergic activity
07/10/2007US7241810 For therapy of inflammatory, allergic and respiratory diseases
07/10/2007US7241775 Composition, process of making, and medical use of substituted 4-phenyltetrahydroisoquinolines
07/10/2007US7241774 Amines such as 6,7-bis-hydroxy-1-biphenyl-4-ylmethyl-1,2,3,4-tetrahydro-isoquinoline, used as preferential anticarcinogenic agents
07/05/2007WO2007076116A2 Intermediates for preparing solifenacin
07/05/2007WO2007074753A1 Pharmaceutical comprising substituted urea derivative
07/05/2007WO2007058583A3 Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies
07/05/2007US20070155959 Protease inhibitor conjugates and antibodies useful in immunoassay
07/05/2007US20070155813 Such as methyl 3,5-dihydroxy-2-phenylphenylacetate; antitumor activity; leukemia, multiple myeloma, lymphoma; heat shock protein 90 (Hsp90) suppression
07/05/2007US20070155790 Meta-benzamidine derivatives as serine protease inhibitors
07/05/2007US20070155784 Novel nitrogen-containing heteroaryl compounds and methods of use thereof
07/05/2007US20070155783 Substituted cyclohexyl and piperidinyl derivates as melanocortin-4 receptor modulators
07/05/2007US20070155778 4-Trifluoromethoxyphenoxybenzol-4-Sulfonic Acids, Method For The Production And Use Thereof In Medicaments
07/05/2007US20070155671 e.g. N-[2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]carbonyl]benzoyl]-3-(phenylmethyl)amino-L-alanine; intercellular adhesion molecules blocking agent; antiinflammatory; reperfusion injury following acute myocardial infarction
07/05/2007DE102005062987A1 Substituierte Propiolsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln Substituted Propiolsäureamide and their use for the preparation of medicaments
07/05/2007CA2631777A1 Substituted isoquinoline-1,3(2h,4h)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3(2h)-isoquinolones and use thereof as kinase inhibitor
07/05/2007CA2630846A1 Intermediates for preparing solifenacin
07/04/2007EP1802574A2 Methods of treatment of amyloidosis using ethanol cyclicamine derivatives aspartyl protease inhibitors
07/04/2007CN1993340A Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression
07/04/2007CN1993326A Heterocyclic acetophenone potentiators of metabotropic glutamate receptors
07/03/2007US7238707 Substituted pentanols, a process for their production and their use as anti-inflammatory agents
07/03/2007US7238685 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating vasoconstriction, proliferation and inflammation
06/2007
06/28/2007WO2007073200A1 Pet radiotracers
06/28/2007WO2007072089A1 Mglur5 antagonistic carbamoyl-oxime derivatives
06/28/2007WO2007072041A1 Therapeutic compounds
06/28/2007WO2006135712A3 (5z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5h)-one
06/28/2007US20070149565 Nelfinavir conjugates and antibodies useful in immunoassay
06/28/2007US20070148708 Protease inhibitor conjugates and antibodies useful in immunoassay
06/27/2007EP1799646A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
06/27/2007CN1989100A Therapeutic compounds
06/27/2007CN1988907A Dual small molecule inhibitors of cancer and angiogenesis
06/26/2007US7235664 Potassium channel modulators; antiarrhythmia agents
06/21/2007US20070142430 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, and methods for the production and use thereof
06/21/2007US20070142333 Cycloalkyl inhibitors of potassium channel function
06/21/2007US20070141643 Protease inhibitor conjugates and antibodies useful in immunoassay
06/20/2007EP1798231A2 Intermediate products for the preparation of antibacterial compounds
06/20/2007EP1797100A1 Nitrate esters and their use for mitigating cellular damage
06/20/2007EP1797065A2 Acyclic 1,3-diamines and uses therefor
06/20/2007CN1984889A Organometallic complex, luminous solid, organic EL element and organic EL display
06/20/2007CN1984660A 4-arylamino-quinazolines as activators of aspartic acid specificity cysteine protease and inducers of apoptosis
06/20/2007CN1982298A Hydro diamine compound, its production and use and composition containing it
06/14/2007WO2007030582A3 Acyclic ikur inhibitors
06/14/2007US20070134161 Methods of determining beta-iii tubulin expression
06/13/2007EP1794128A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, their use as a medicament, and a medicament containing them
06/13/2007EP1214292B1 Tyrosine derivatives
06/13/2007CN1980895A 1-aryl-4-substituted isoquinolines
06/13/2007CN1980892A Dpp-IV inhibitors
06/07/2007WO2007064749A1 Compounds for the treatment of inflammatory disorders and microbial diseases
06/07/2007WO2007064732A1 Compounds for the treatment of inflammatory disorders and microbial diseases
06/07/2007US20070129399 Tetrahydroisoquinoline-and tetrahydrobenzazepine derivatives as igf-1r inhibitors
06/07/2007CA2632922A1 Compounds for the treatment of inflammatory disorders and microbial diseases
06/07/2007CA2632921A1 Compounds for the treatment of inflammatory disorders and microbial diseases
06/06/2007EP1791536A1 1-[(3r)-amino-4-(2-fluoro-phenyl)-butyl]-pyrrolidine-(2r)-carboxylic acid-benzyl amine derivatives and related compounds as dipeptidyl-peptidase iv (dpp-iv) inhibitors for the treatment of type 2 diabetes mellitus
06/06/2007DE102005058166A1 Matrixkontrolliertes transdermales System mit Amin-Salzen der ACE-Hemmer-Dicarbonsäuren Controlled matrix transdermal system with amine salts of the ACE inhibitor dicarboxylic acids
06/06/2007CN1976907A Heterocyclic amide compound and use thereof as an MMP-13 inhibitor
05/2007
05/31/2007WO2007060026A1 Urea derivatives useful as calcium receptor modulators
05/31/2007WO2007022964A3 Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-ht5-receptors
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 119